IRTC

In a report released yesterday, Marie Thibault from BTIG reiterated a Buy rating on Irhythm Technologies (IRTC - Research Report), with a price target of $168.00. The company's shares closed yesterday at $126.77.Thibault covers the Healthcare sector, focusing on stocks such as Masimo, Irhythm Technologies, and Atricure. According to TipRanks, Thibault has an average return of 5.0% and a 35.09% success rate on recommended stocks. Currently, the analyst consensus on Irhythm Technologies is a Strong Buy with an average price target of $174.29, implying a 37.49% upside from current levels. In a report released on October 17, Truist Financial also maintained a Buy rating on the stock with a $167.
https://www.tipranks.com/news/blurbs/btig-remains-a-buy-on-irhythm-technologies-irtc-2?utm_source=advfn.com&utm_medium=referral